HIV/AIDS

Paragraphs
Media
Laboratory reagent
Laboratory reagent
Caption
Photo Credit: Vanessa Vick/IAVI
Body Text

The global HIV community has made tremendous progress in turning the tide of the HIV pandemic, reducing incidence and prevalence in many countries and reaching millions of people with testing and treatment. Stronger public health supply chains have played a key role in this progress by increasing access to HIV commodities.

The USAID Global Health Supply Chain Program-Procurement and Supply Management (GHSC-PSM) project provides two key services to support countries in reaching their 90-90-90 HIV testing, treatment, and viral load suppression targets: (1) provision of a secure supply of commodities, and (2) systems strengthening technical assistance.

Heading
Core Activities
Body

GHSC-PSM provides assistance that is targeted to support countries in meeting their unique procurement and supply chain challenges and, in some cases, to cut the cost of doing so. We work with suppliers of pharmaceuticals (antiretrovirals [ARVs] and essential medicines), male circumcision commodities, and laboratory instruments and commodities to reach this goal. The project collaborates with the Global Health Supply Chain-Rapid Test Kits (GHSC-RTK) project by providing country quantifications of demand for test kits. GHSC-PSM also works with Global Health Supply Chain-Quality Assurance (GHSC-QA) to ensure the quality of all HIV-related commodities.

Led by PEPFAR, UNAIDS, WHO, and others global stakeholders, many HIV/AIDS programs are transitioning to a new antiretroviral drug regimen, TLD (tenofovir, lamivudine, dolutegravir). GHSC-PSM is playing a vital role in supporting HIV/AIDS programs in managing their transition to TLD.

Our project teams work in 24 countries, providing a mix of technical assistance and/or commodity procurement support to strengthen local capacity in HIV supply chains. Building on a decade of work by USAID, PEPFAR, and implementing partners, our teams work with local partners to provide new approaches to strategic planning, logistics, data visibility and analytics, and capacity building.

Current country and regional presence includes: Angola, Botswana, Burundi, Cambodia, Cameroon, Caribbean, Central America, Ethiopia, Ghana, Guyana, Haiti, Indonesia, Lesotho, Malawi, Mozambique, Namibia, Nigeria, Rwanda, South Sudan, Uganda, Vietnam, Zambia, and Zimbabwe.

Heading
Key Commodities
Body

Key commodities include:

  • First-line adult antiretroviral medicines (ARVs)
  • Second-line adult antiretroviral medicines (ARVs)
  • First-line pediatric antiretroviral medicines (ARVs)
  • All laboratory commodities
  • Condoms
  • Voluntary medical male circumcision
  • Other related commodities
Heading
Global Goals
Body

GHSC-PSM supports bold targets set by the U.S. government in 2015 for PEPFAR to support 12.9 million people with life-saving antiretroviral treatment and 13 million men with male circumcision by the end of 2017.

Specifically, our project advances PEPFAR’s work to support partner countries to rapidly adopt and implement World Health Organization (WHO) guidelines for “Test and Start” as well as more efficient service delivery models. These WHO guidelines are designed to prevent new HIV infections, save more lives, and accelerate progress toward the UNAIDS 90-90-90 goals for 2020:

  • 95 percent of people with HIV diagnosed
  • 95 percent of those diagnosed on antiretroviral treatment (ART)
  • 95 percent of those on ART virally suppressed

GHSC-PSM contributes to each of the 95-95-95 targets through procurement and technical assistance. We collaborate closely with the Global Fund to Fight AIDS, Tuberculosis and Malaria and U.S. Centers for Disease Control and Prevention through USAID to harmonize approaches, such as procurement of viral load instruments.

We also work with our country programs to ensure that the most recent information about new ARVs and the most effective ARV regimens is informing their work with ministries of health. 

Heading
Strategic Partnerships
Body

GHSC-PSM works to build and maintain strategic partnerships and to support USAID’s leadership among key stakeholders in the global community. Most notable in the HIV/AIDS arena are partnerships with The Global Fund, the World Health Organization, the African Society for Laboratory Medicine, and consortia such as the Antiretroviral Procurement Working Group and initiatives such as the UNITAID-funded Point of Care Early Infant Diagnosis Partner Consortium.

The project’s market dynamics efforts aim to further shape and strengthen the market for ARVs, HIV rapid test kits, viral load laboratory equipment and supplies, and other key commodities. Based on needs identified by market dynamics analysis, GHSC-PSM also advocates for changes in policy and practice.

News & Highlights

Photo Essay
January 24, 2020
In Zimbabwe, electrical outages, fuel shortages and doctor strikes are taking the public health system to a crisis point. Yet the HIV/AIDS supply chain continues to perform normally. This photo essay explains how a strong partnership between NatPharm (central medical store) and GHSC-PSM ensures…
News Article
January 10, 2020
Often the real supply chain heroes are hidden from public view and work tirelessly behind the scenes, making sure the health supply chain runs smoothly. Patients value the care of extraordinary doctors, nurses and therapists, but rarely are health center information technology (IT) personnel…
Video
November 25, 2019
In our support  to USAID, PEPFAR and the U.S. President's Malaria Initiative in more than 60 countries, we work with partners like IBM to use technology to build smarter and more efficient supply chains, helping to improve lives. Check out the video to see how we work together to do so.

Success Stories

September 17, 2019
A 2014 assessment of over 730 public health facilities in Malawi found that more than three quarters of them had less than half of the pharmacy storage space needed to meet existing demands, a situation that would only get worse as the population grew
November 8, 2019
The global effort to optimize antiretroviral (ARV) treatment is an ongoing commitment to people living with HIV (PLHIV) to improve the efficacy, reduce the costs, and limit the side-effects of their treatment.